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Abstract
Aim To evaluate the association between health-related quality of life and glucose metabolism status in a study
population in Qazvin, Iran.
Methods This cross-sectional study was conducted in 1044 people (aged 20–78 years old) between September 2010
and April 2011 in Qazvin, Iran. An oral glucose tolerance test was performed for each participant who had never been
diagnosed with diabetes. Participants were characterized as having normal glucose metabolism, pre-diabetes or diabetes
according to American Diabetes Association criteria. The short-form 36 questionnaire was used to measure quality of
life. Data were analysed using a chi-squared test, ANOVA and ANCOVA.
Results A total of 530 (51.7%) of the participants were women, and 24.1 and 11.6% of the participants were
categorized as having prediabetes and diabetes mellitus, respectively. Except for the role emotional domain, there was a
gradual decrease in the mean scores of every domain of the short-form 36 scale across the three study groups. The mean
scores in the physical domains were significantly different among the participants with normal glucose metabolism and
those with diabetes. After adding age as covariate, there were no significant differences between the categories in any of
the domains.
Conclusion There is no association between quality of life domains and glucose metabolism status in Iranian subjects.
More longitudinal studies are necessary to investigate the natural history of pre-diabetes, diabetes and quality of life.
Diabet. Med. 31; 754–758 (2014)
Introduction
Health-related quality of life is an important factor in
chronic diseases where a cure is unlikely. Chronic disease
may result in greater concern about function and well-being
than the physiological measures that healthcare providers
consider useful [1].
The prevalence of diabetes mellitus has increased so
rapidly worldwide that it has reached epidemic proportions.
[2] It is a major cause of morbidity and mortality, and has
been associated with a poor quality of life [3]. Pre-diabetes is
a state of abnormal glucose homeostasis which presents as
impaired fasting glucose, impaired glucose tolerance, or
both [4]. Diabetologists agree that pre-diabetes should be
termed a disease [5]. Impaired glucose metabolism causes
macrovascular diseases and Type 2 diabetes, which contrib-
utes to microvascular disease [5].
Although diabetes has an obvious impact on health-re-
lated quality of life, the association between pre-diabetes
and change in well-being and health-related quality of life
needs further evaluation [6]. It is unclear whether quality
of life is diminished at or before the onset of diabetes,
among those with pre-diabetes [3]. This stimulated our
interest in examining the association between health-related
quality of life and glucose metabolism status in Qazvin,
Iran.
Subjects and methods
This cross-sectional study was conducted in 1107 people
between September 2010 and April 2011 in Qazvin, which is
located 150 km northwest of Tehran, Iran. The research
project was approved by the medical research ethics com-
mittee of Qazvin University of Medical Sciences.Correspondence to: Neda Esmailzadehha. E-mail: nesmailzadehha@qums.ac.ir
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The study participants were selected by multistage cluster
random sampling methods from residents of the Mindoodar
district of Qazvin. Potential participants were invited by
telephone to attend the study at the health centre and, after
explanation of the study details, they were free to participate.
All participants gave their written informed consent. Demo-
graphic and social data were self-reported in the question-
naire given to the participants. Details of the sampling
method and data collection have been reported elsewhere [7].
A venous blood sample from each participant was taken
after a 12–4-h overnight fast. All the samples were analysed
at the same laboratory on the day of blood collection. Blood
glucose level was measured in all participants. An oral
glucose tolerance test was performed for all the participants
who had never been diagnosed with diabetes.
Impaired fasting glucose was defined as fasting plasma
glucose levels ≥5.6 mmol/L but <7.0 mmol/L. Impaired
glucose tolerance was defined as 2-h values in the oral
glucose tolerance test ≥7.8 mmol/L but <11.1 mmol/L.
Impaired fasting glucose and impaired glucose tolerance
were considered to indicate pre-diabetes. Diabetes was
defined as fasting plasma glucose ≥7.0 mmol/L or 2-h
post-load glucose ≥11.1 mmol/L during an oral glucose
tolerance test, or previous diagnosis of diabetes [8]. Accord-
ing to glucose metabolism status, the study population was
divided in three groups: participants with normal glucose
metabolism, those with pre-diabetes and those with diabetes.
To assess participants’ health-related quality of life, we
used the short-form health survey 36 questionnaire (SF-36).
Data from the SF-36 questionnaire were self-reported. This
questionnaire includes 36 questions that measure eight
separate domains: physical functioning; role physical; bodily
pain; general health; vitality; social functioning; role emo-
tional and mental health. Each domain is scored from 0 to
100, where higher scores correspond to a better health-re-
lated quality of life [9]. Socio-demographic characteristics of
the study participants are presented as frequency and
percentages, while health- related quality of life domain
scores are given as mean (SD) values. Data were analysed
using a chi-squared test and ANOVA. An ANCOVA test was used
to adjust for the effect of age and other confounders. The
adjusted health-related quality of life domain scores are
reported as mean (SE) values. P values < 0.05 were considered
to indicate statistical significance.
Results
A total of 529 men and 578 women aged 20–78 years [mean
(SD) age 40.08 (10.33) years] enrolled in the study, and of
these, 1044 had complete questionnaires and laboratory
tests. Of these 1044 participants, 530 (51.7%) were women,
and 24.1 and 11.6% were categorized as having pre-diabetes
and diabetes mellitus according to American Diabetes
Association criteria, respectively. The socio-demographic
characteristics of the participants are shown in Table 1.
Participants with normal glucose metabolism were younger
than those in the pre-diabetes or the diabetes study groups.
The crude and adjusted mean health-related quality-of-life
scores for each domain of the SF-36 scale for each of the
three study groups and adjusted P values are shown in
Table 2. Except for role emotional, there was a gradual
decrease in the mean scores for every domain of the SF-36
scale across the three study groups. The mean scores for the
physical domains were significantly different among the three
groups. A post hoc test showed that these differences were
attributable to the differences between the normal glucose
metabolism and diabetes groups. The mean scores for all
domains were not significantly different between participants
with normal glucose metabolism and those with pre-diabetes.
The only significant difference for participants with pre-dia-
betes compared with participants with diabetes was in the
physical functioning domain (P = 0.01). The differences in
mean scores for mental domains were not statistically
significant among the study groups. After adjusting for
gender using an ANCOVA test, the differences among the
groups in the physical domains of the SF-36 remained
significant. There were no significant differences among the
study groups in any domain score when age was added as a
covariate.
Discussion
Focus on health-related quality of life has increased consid-
erably. It is accepted that people with diabetes have
significantly lower health-related quality of life compared
with those who do not have diabetes [10]. The prevalence of
diabetes and pre-diabetes is increasing annually worldwide
[5,11,12]. People with pre-diabetes are at increased risk of
diabetes [2,11] and cardiovascular events [8,13]. The prev-
alence of obesity is increasing worldwide, which will increase
the burden of pre-diabetes and diabetes [14].
The present study is one of the few studies to investigate
the association between glucose metabolism status and
quality of life using a population-based design and an oral
What’s new?
• This study is one of the few studies that investigate the
association between glucose metabolism status and
quality of life in a population-based design using an
oral glucose tolerance test.
• It is unclear whether quality of life is diminished at or
before the onset of diabetes, among those with pre-dia-
betes. In the present study we examine health-related
quality of life among people with diabetes, people with
pre-diabetes and people with normal glucose metabo-
lism.
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glucose tolerance test. In the present study we found a
gradual decrease in quality of life among three categories of
glucose metabolism. This is consistent with two earlier
studies by Hiltunen et al. [15] and Tapp et al. in their
Australian Diabetes and Lifestyle (AusDiab) study [3], which
assessed similar areas and showed a general pattern of
worsening quality of life across glucose metabolism catego-
ries [3,15]. The follow-up of the AusDiab study showed that
impaired fasting glucose and impaired glucose tolerance
(pre-diabetes), as well as diabetes at baseline, reduce
health-related quality of life [16].
In the present study, the initial analysis showed that the
differences between categories were statistically significant.
People with Type 2 diabetes had a lower health-related
quality of life in all physical domains and their scores were
significantly different from those with normal glucose
metabolism; however, the observed association of glucose
metabolism status with health-related quality of life was
attributable to age. The increasing prevalence of diabetes
with age is the most likely explanation for this observation
[17]. Consistent with studies by Schunk et al. [18] and de
Zwaan et al. [19], age seems to impair physical health-re-
lated quality of life substantially. In another study, Sepp€al€a
et al. [20] excluded patients with established cardiovascular
disease and previously diagnosed diabetes, and found that
the deterioration in health-related quality of life in subjects
with impaired fasting glucose or impaired glucose tolerance
was not significant.
The scores for the mental domains of the SF-36 showed a
similar pattern of gradual decrease but the differences did not
reach statistical significance. It can be concluded that poor
glycaemic control is related to poorer quality of life in
physical aspects [21]. In a study by H€akkinen et al. [22], the
health-related quality of life of people at risk for Type 2
diabetes was compared with that of the Finnish general
population. They showed that the health-related quality of
life of those at risk was significantly lower in the general
health and bodily pain domains but, conversely, mental
health and role emotional dimensions were better than in the
general population. In a cross-sectional study, Mena Martın
et al. [23] showed that patients with diabetes had lower
scores in the physical function, bodily pain, general health
Table 1 Socio-demographic characteristics of the study participants
Study group
Total Diabetes Pre-diabetes Normal glucose metabolism P
Sex, n (%)
Male 513 48 (9.4) 150 (29.2) 315 (61.4) <0.001
Female 530 66 (12.5) 103 (19.4) 361 (68.1)
Age, mean (SD) 47.04 (9.38) 43.80 (9.50) 37.68 (9.88) <0.001
Educational level, n (%)
No formal education 32 10 (31.2) 10 (31.2) 12 (37.5) <0.001
<12 years 805 91 (11.3) 198 (24.6) 516 (64.1)
>12 years 201 11 (5.5) 44 (21.9) 146 (72.6)
Work status, n (%)
Employed 391 25 (6.4) 91 (23.3) 275 (70.3) <0.001
Unemployed 53 0 (0) 13 (24.5) 40 (75.5)
Housewife 421 61 (14.5) 91 (21.6) 269 (63.9)
Pensioner (Retired) 171 28 (16.4) 55 (32.2) 88 (51.5)
Table 2 Short-form health survey-36 scores for health-related quality of life in the three study groups
Crude scores, mean (SD) Age- and gender-adjusted scores, mean (SE)
Normal glucose
metabolism Pre-diabetes Diabetes P
Normal glucose
metabolism Pre-diabetes Diabetes P
Domain
Physical functioning 80.95 (20.91) 79.09 (21.17) 71.97 (25.80) <0.001 79.85 (0.824) 80.74 (1.368) 76.32 (2.03) NS
Role physical 72.30 (33.26) 67.29 (35.56) 62.06 (38.39) <0.001 71.25 (1.33) 68.13 (2.21) 67.07 (3.29) NS
Bodily pain 65.34 (20.59) 63.24 (21.37) 60.17 (25.38) <0.001 64.94 (0.814) 62.80 (1.35) 63.18 (2.01) NS
General health 63.59 (17.32) 61. 20 (18.52) 58.10 (18.34) <0.001 63.33 (0.69) 61.45 (1.14) 59.41 (1.70) NS
Vitality 62.06 (18.09) 61.02 (17.72) 60.57 (19.97) NS 62.07 (0.705) 60.57 (1.17) 61.80 (1.74) NS
Social functioning 75.72 (20.70) 75.14 (21.60) 70.83 (24.25) NS 75.73 (0.83) 75.70 (1.39) 71.50 (2.07) NS
Role emotional 66.56 (37.97) 70.48 (35.36) 62.57 (40.19) NS 67.13 (1.47) 69.38 (2.44) 62.57 (3.64) NS
Mental health 67.07 (17.64) 66.33 (17.73) 65.68 (19.86) NS 66.99 (0.70) 65.78 (1.16) 66.24 (1.73) NS
NS, nonsignificant.
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and vitality domains but their social function and mental
health were not affected.
The present study showed that the mean score for the
physical functioning domain of the SF-36 in participants with
pre-diabetes was significantly different from that in partic-
ipants with diabetes and this association was also related to
age. Symptoms of diabetes develop so gradually that many
people do not recognize them; most people with pre-diabetes
or diabetes are unaware of their glycaemic state [24]. People
with pre-diabetes may already have some of the problems
associated with diabetes. Complications resulting from
diabetes, treatment, glycaemic control and psychological
aspects may adversely affect many aspects of a patient’s life,
including their quality of life [25].
In the present study, gender did not affect the association
between glucose metabolism status and physical health-re-
lated quality of life. Schunk et al. [18], in a study using the
short-form health survey 12 questionnaire, showed that
women with Type 2 diabetes had a significantly lower mental
component summary. Older people in that study had a lower
physical component summary, but a higher mental compo-
nent summary was found for people with and without Type 2
diabetes. It must be considered that the higher the number of
chronic and somatic illnesses and the higher the BMI, the
more deterioration in physical health-related quality of life
would be reported [19]. Nevertheless, factors that may affect
women with impaired glucose metabolism should be
researched more thoroughly.
The negative consequences of Type 2 diabetes on heal-
th-related quality of life highlight the burden of the disease
and the importance of prevention programmes. Medical
experts concur that one of the major challenges associated
with diabetes is prevention [26,27]. It has been shown that the
Diabetes Prevention Program can prevent or delay the
development of Type 2 diabetes in people with impaired
glucose tolerance [12,28]. There is strong evidence from
many clinical trials indicating that lifestyle changes can
prevent or delay Type 2 diabetes in the at-risk groups [29,30].
Any prevention programme needs to focus on identifying and
providing access to effective behavioural and lifestyle inter-
vention in people at high risk of diabetes [27].
Primary and secondary prevention strategies are necessary
to control diabetes, which will bring positive effects on the
health-related quality of life of affected people [10]. Diabetes
causes debilitating, costly and deadly complications that are
more common or more severe when diabetes is poorly
controlled [11].
Diabetes is often noted as a disease of affluence, so health
education could help in promoting the lifestyle changes that
are the most influential in preventing its onset in people with
pre-diabetes [11,27]. Structured lifestyle changes and certain
pharmacotherapies are beneficial in preventing or delaying
the development of diabetes in people with pre-diabetes
[8,11], but their impact on reducing mortality or the
incidence of cardiovascular disease is unknown [8].
A strength of the present study is that the participants with
pre-diabetes completed the SF-36 questionnaire before they
knew the results of their oral glucose tolerance test, so the
diagnosis of pre-diabetes did not affect the participants’
perceived quality of life.
The present study also has some limitations, which include
its cross-sectional design and the number of studied subjects.
The authors grouped previously and newly diagnosed par-
ticipants with diabetes into the same category and their
scores were not compared. It has been recommended that a
diabetes-specific measure for assessing health-related quality
of life should be used in addition to the SF-36 scale, but in the
present study we did not use a diabetes-specific measure.
In conclusion, there was no association between qual-
ity-of-life domains and glucose metabolism status in our
Iranian study population. More longitudinal studies are
necessary to investigate the natural history of pre-diabetes,
diabetes and quality of life. As a result of increasing life
expectancy and the association of Type 2 diabetes with age, a
focus on preventive programmes is necessary.
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